Description
NSE admits further securities of nine companies to dealings on the Capital Market segment effective April 17, 2026, covering Rights Issue, ESOP allotments, and warrant conversions.
Summary
NSE issued circular ref. NSE/CML/73766 (0636/2026) on April 16, 2026, notifying that further securities of nine companies have been admitted to dealings on the National Stock Exchange Capital Market segment effective April 17, 2026. The allotments cover Rights Issue shares, ESOP shares, and shares issued on conversion of warrants on a preferential basis.
Key Points
- Effective date for all new listings: April 17, 2026
- Issued under Regulation 3.1.1 and 2.5.5 of NSE (Capital Market) Trading Regulations Part A
- All newly listed securities are pari passu with existing shares except Ind-Swift Laboratories which carries a lock-in until October 20, 2027
- Market lot size is 1 for all listed securities
- Nine companies across diverse sectors are covered in this circular
Regulatory Changes
No new regulatory changes introduced. This circular operates under existing NSE Capital Market Trading Regulations (Regulation 3.1.1 for admission to dealings and Regulation 2.5.5 for lot sizes).
Compliance Requirements
- Members must use the designated security codes and specified lot sizes for trading
- Trading in newly admitted securities must comply with applicable lot sizes as specified in the Annexure
- Lock-in restrictions must be observed for Ind-Swift Laboratories shares (lock-in expiry: October 20, 2027)
Important Dates
| Company | Allotment Date | Effective Trading Date |
|---|---|---|
| 5Paisa Capital Limited | April 13, 2026 | April 17, 2026 |
| Equitas Small Finance Bank | April 06, 2026 | April 17, 2026 |
| Brainbees Solutions (FirstCry) | March 27, 2026 | April 17, 2026 |
| ICICI Prudential Life Insurance | April 15, 2026 | April 17, 2026 |
| Ind-Swift Laboratories | February 24, 2026 | April 17, 2026 |
| Marine Electricals (India) | Not specified in excerpt | April 17, 2026 |
| Ugro Capital Limited | Not specified in excerpt | April 17, 2026 |
| UTI Asset Management Company | Not specified in excerpt | April 17, 2026 |
| V.S.T Tillers Tractors Limited | Not specified in excerpt | April 17, 2026 |
- Lock-in Expiry for Ind-Swift Laboratories warrant-conversion shares: October 20, 2027
Impact Assessment
5Paisa Capital Limited (5PAISA): Largest issue by volume — 15,627,419 Rights Issue shares (ISIN: INE618L01018) at Rs. 300 each (face value Rs. 10). Significant equity dilution; rights-issue shares are pari passu with no lock-in.
Equitas Small Finance Bank (EQUITASBNK): 242,057 ESOP shares (ISIN: INE063P01018) at face/paid-up value of Rs. 10. Minimal dilution impact given small volume relative to total share capital.
Brainbees Solutions / FirstCry (FIRSTCRY): 8,143 ESOP shares (ISIN: INE02RE01045) at face value Rs. 2. Negligible dilution.
ICICI Prudential Life Insurance (ICICIPRULI): 209,760 ESOP shares (ISIN: INE726G01019) at face value Rs. 10. Minor dilution.
Ind-Swift Laboratories (INDSWFTLAB): 5,100,000 shares (ISIN: INE915B01019) at issue price Rs. 121 (face value Rs. 10) allotted on conversion of warrants on preferential basis. Meaningful dilution; shares subject to lock-in until October 20, 2027, limiting immediate float impact.
Marine Electricals, Ugro Capital, UTI AMC, V.S.T Tillers Tractors: Details partially truncated in source document; further details available in the full circular annexure.
Impact Justification
Routine listing circular admitting further issues across nine companies via different allotment mechanisms. 5Paisa Rights Issue (15.6M shares) and Ind-Swift warrant conversion (5.1M shares) are the largest by volume and have broader market impact; others are smaller ESOP allotments with limited dilution.